Cashu | Summary

DJI

+0.77%

SPX

+0.83%

IXIC

+0.98%

FTSE

+0.42%

N225

+0.81%

AXJO

+0.41%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

HomeWatchlistNewsSignalsPicks

DJI

+0.77%

SPX

+0.83%

IXIC

+0.98%

FTSE

+0.42%

N225

+0.81%

AXJO

+0.41%

HomeWatchlistNewsSignalsPicks

Join our newsletter to keep up to date with us!

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap

73.20M

Dividend Yield

0.00%

P/E Ratio

-1.49

EPS

-1.31

Revenue

Avg. Volume

121.34K

About

What does QNCX do?

Quince Therapeutics, based in South San Francisco, develops therapeutics using its AIDE technology to encapsulate drugs in patients' red blood cells, targeting rare diseases like Ataxia-Telangiectasia. The company went public on May 9, 2019, and employs 32 people.

Sector

💻 Health Care

IPO

CEO

Employees

Headquarters

California, USA

Website

http://www.cortexyme.com